168 related articles for article (PubMed ID: 9326762)
41. An ocular mucosal administration of nanoparticles containing DNA vaccine pRSC-gD-IL-21 confers protection against mucosal challenge with herpes simplex virus type 1 in mice.
Hu K; Dou J; Yu F; He X; Yuan X; Wang Y; Liu C; Gu N
Vaccine; 2011 Feb; 29(7):1455-62. PubMed ID: 21185849
[TBL] [Abstract][Full Text] [Related]
42. Improvement of herpetic stromal keratitis with fumaric acid derivate is associated with systemic induction of T helper 2 cytokines.
Heiligenhaus A; Li H; Schmitz A; Wasmuth S; Bauer D
Clin Exp Immunol; 2005 Oct; 142(1):180-7. PubMed ID: 16178874
[TBL] [Abstract][Full Text] [Related]
43. Lactoferrin inhibits herpes simplex virus type-1 (HSV-1) infection to mouse cornea.
Fujihara T; Hayashi K
Arch Virol; 1995; 140(8):1469-72. PubMed ID: 7661698
[TBL] [Abstract][Full Text] [Related]
44. Phenotypic and genotypic characterization of acyclovir-resistant corneal HSV-1 isolates from immunocompetent patients with recurrent herpetic keratitis.
Burrel S; Boutolleau D; Azar G; Doan S; Deback C; Cochereau I; Agut H; Gabison EE
J Clin Virol; 2013 Sep; 58(1):321-4. PubMed ID: 23731845
[TBL] [Abstract][Full Text] [Related]
45. Topical treatment with antisense oligonucleotides targeting tumor necrosis factor-alpha in herpetic stromal keratitis.
Wasmuth S; Bauer D; Yang Y; Steuhl KP; Heiligenhaus A
Invest Ophthalmol Vis Sci; 2003 Dec; 44(12):5228-34. PubMed ID: 14638721
[TBL] [Abstract][Full Text] [Related]
46. Acyclovir for the treatment and prevention of recurrent infectious herpes simplex keratitis.
Wu X; Chen X
Chin Med J (Engl); 2002 Oct; 115(10):1569-72. PubMed ID: 12490113
[TBL] [Abstract][Full Text] [Related]
47. Reversible nerve damage and corneal pathology in murine herpes simplex stromal keratitis.
Yun H; Rowe AM; Lathrop KL; Harvey SA; Hendricks RL
J Virol; 2014 Jul; 88(14):7870-80. PubMed ID: 24789786
[TBL] [Abstract][Full Text] [Related]
48. In vitro and in vivo antiherpetic effects of (1R,2R)-1-(5'-methylful-3'-yl)propane-1,2,3-triol.
Sasaki K; Hayashi K; Matsuya Y; Sugimoto K; Lee JB; Kurosaki F; Hayashi T
J Nat Med; 2016 Apr; 70(2):217-24. PubMed ID: 26763002
[TBL] [Abstract][Full Text] [Related]
49. Control of herpetic stromal keratitis using CTLA4Ig fusion protein.
Gangappa S; Manickan E; Rouse BT
Clin Immunol Immunopathol; 1998 Jan; 86(1):88-94. PubMed ID: 9434800
[TBL] [Abstract][Full Text] [Related]
50. A-5021: a new acyclovir analogue inhibits murine herpetic keratitis.
Itahashi M; Higaki S; Sugahara D; Sugioka K; Deai T; Takao K; Hayashi K; Shimomura Y
Cornea; 2008 Apr; 27(3):334-8. PubMed ID: 18362663
[TBL] [Abstract][Full Text] [Related]
51. The role of cytokines in experimental herpes simplex keratitis.
Arrunategui-Correa V; Baltatzis S; Foster CS
Acta Virol; 1999 Oct; 43(5):325-9. PubMed ID: 10757234
[TBL] [Abstract][Full Text] [Related]
52. Herpes simplex virus-specific T cells infiltrate the cornea of patients with herpetic stromal keratitis: no evidence for autoreactive T cells.
Verjans GM; Remeijer L; Mooy CM; Osterhaus AD
Invest Ophthalmol Vis Sci; 2000 Aug; 41(9):2607-12. PubMed ID: 10937573
[TBL] [Abstract][Full Text] [Related]
53. Influence of dimethylfumarate on experimental HSV-1 necrotizing keratitis.
Heiligenhaus A; Li H; Wasmuth S; Bauer D
Graefes Arch Clin Exp Ophthalmol; 2004 Oct; 242(10):870-7. PubMed ID: 15241613
[TBL] [Abstract][Full Text] [Related]
54. Role of macrophages in restricting herpes simplex virus type 1 growth after ocular infection.
Cheng H; Tumpey TM; Staats HF; van Rooijen N; Oakes JE; Lausch RN
Invest Ophthalmol Vis Sci; 2000 May; 41(6):1402-9. PubMed ID: 10798656
[TBL] [Abstract][Full Text] [Related]
55. Acyclovir resistance in herpes simplex virus isolates from keratitis cases: an analysis from a developing country.
Pramod NP; Thyagarajan SP; Mohan KV; Anandakannan K
Microbiol Immunol; 2000; 44(4):241-7. PubMed ID: 10832967
[TBL] [Abstract][Full Text] [Related]
56. Efficacy of herpes virus helicase-primase inhibitor, ASP2151, for treating herpes simplex keratitis in mouse model.
Sasaki S; Miyazaki D; Haruki T; Yamamoto Y; Kandori M; Yakura K; Suzuki H; Inoue Y
Br J Ophthalmol; 2013 Apr; 97(4):498-503. PubMed ID: 23361434
[TBL] [Abstract][Full Text] [Related]
57. In vivo anti-herpes simplex virus activity of a sulfated derivative of Agaricus brasiliensis mycelial polysaccharide.
Cardozo FT; Larsen IV; Carballo EV; Jose G; Stern RA; Brummel RC; Camelini CM; Rossi MJ; Simões CM; Brandt CR
Antimicrob Agents Chemother; 2013 Jun; 57(6):2541-9. PubMed ID: 23507287
[TBL] [Abstract][Full Text] [Related]
58. Herpes simplex keratitis in South India: clinico-virological correlation.
Pramod NP; Rajendran P; Kannan KA; Thyagarajan SP
Jpn J Ophthalmol; 1999; 43(4):303-7. PubMed ID: 10482477
[TBL] [Abstract][Full Text] [Related]
59. The role of Igh-1 disparate congenic mouse T lymphocytes in the pathogenesis of herpetic stromal keratitis.
Akova YA; Dutt J; Rodriguez A; Jabbur N; Foster CS
Curr Eye Res; 1993 Dec; 12(12):1093-101. PubMed ID: 7907969
[TBL] [Abstract][Full Text] [Related]
60. [Suppression effects of interleukin-10 on mouse herpetic stromal keratitis].
Xia LK; Gao DW; Pu W; Zhang JS
Zhonghua Yan Ke Za Zhi; 2003 Oct; 39(10):592-6. PubMed ID: 14766072
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
